Literature DB >> 22113252

Interaction of St John's wort (Hypericum perforatum) with clozapine.

Annelies C P Van Strater1, Jan P A M Bogers.   

Abstract

St John's wort (Hypericum perforatum) is notorious for its ability to induce the enzymes of the P450 system. Especially, it induces CYP1A2 and CYP3A4, enzymes that are closely involved in the metabolism of clozapine. We present a patient with schizophrenia, who was stable on a fixed dose with stable plasma level of clozapine, and who deteriorated after she started self-medicating with St John's wort. The reduced plasma clozapine level and the psychiatric condition normalized after the withdrawal of St John's wort. It is possible that, beside the induction of P450-enzymes, the induction of P-glycoprotein by St John's wort aggravated psychiatric deterioration of the patient. Physicians should be alert to patients self-medicating with over-the-counter medicines, especially when these medicines can lower clozapine concentrations below the therapeutic range.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22113252     DOI: 10.1097/YIC.0b013e32834e8afd

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  13 in total

Review 1.  Critical evaluation of causality assessment of herb-drug interactions in patients.

Authors:  Charles Awortwe; Memela Makiwane; Helmuth Reuter; Christo Muller; Johan Louw; Bernd Rosenkranz
Journal:  Br J Clin Pharmacol       Date:  2018-01-29       Impact factor: 4.335

Review 2.  Psychotropic drug-drug interactions involving P-glycoprotein.

Authors:  Yumiko Akamine; Norio Yasui-Furukori; Ichiro Ieiri; Tsukasa Uno
Journal:  CNS Drugs       Date:  2012-11       Impact factor: 5.749

Review 3.  St. John's wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?

Authors:  Gita Kholghi; Shirin Arjmandi-Rad; Mohammad-Reza Zarrindast; Salar Vaseghi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-03-16       Impact factor: 3.000

4.  Prevalence and Predictors of Complementary and Alternative Medicine Use in a Large Insured Sample of Children with Autism Spectrum Disorders.

Authors:  Ashli A Owen-Smith; Stephen Bent; Frances L Lynch; Karen J Coleman; Vincent M Yau; Kathryn A Pearson; Maria L Massolo; Virginia Quinn; Lisa A Croen
Journal:  Res Autism Spectr Disord       Date:  2015-09-01

Review 5.  Cytochrome P450 enzyme mediated herbal drug interactions (Part 1).

Authors:  Sompon Wanwimolruk; Virapong Prachayasittikul
Journal:  EXCLI J       Date:  2014-04-02       Impact factor: 4.068

Review 6.  Pharmacogenomics and herb-drug interactions: merge of future and tradition.

Authors:  Mou-Ze Liu; Yue-Li Zhang; Mei-Zi Zeng; Fa-Zhong He; Zhi-Ying Luo; Jian-Quan Luo; Jia-Gen Wen; Xiao-Ping Chen; Hong-Hao Zhou; Wei Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-02       Impact factor: 2.629

7.  St John's wort (Hypericum perforatum)-induced psychosis: a case report.

Authors:  Maria Ferrara; Francesco Mungai; Fabrizio Starace
Journal:  J Med Case Rep       Date:  2017-05-15

8.  Pharmacokinetic Evaluation of Clozapine in Concomitant Use of Radix Rehmanniae, Fructus Schisandrae, Radix Bupleuri, or Fructus Gardeniae in Rats.

Authors:  Dan-Dan Tian; Wei Wang; Hua-Ning Wang; Stephen Cho Wing Sze; Zhang-Jin Zhang
Journal:  Molecules       Date:  2016-05-27       Impact factor: 4.411

Review 9.  Phytotherapeutics: The Emerging Role of Intestinal and Hepatocellular Transporters in Drug Interactions with Botanical Supplements.

Authors:  Ghulam Murtaza; Naveed Ullah; Farah Mukhtar; Shamyla Nawazish; Saiqa Muneer
Journal:  Molecules       Date:  2017-10-21       Impact factor: 4.411

10.  An epidemiological study on herbal product self-medication practice among psychotic outpatients from Serbia: A cross-sectional study.

Authors:  Gordana Nikolić; Nikola M Stojanović; Pavle J Randjelović; Snežana Manojlović; Niko S Radulović
Journal:  Saudi Pharm J       Date:  2018-02-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.